Principal Financial Group Inc Repligen Corp Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$119.79 - $167.35 $6.28 Million - $8.77 Million	-52,435 Reduced 30.23%	120,991 $18 Million
Q2 2024 Jul 29, 2024	SELL	$120.0 - $182.95 $20.6 Million - $31.5 Million	-172,019 Reduced 49.8%	173,426 $21.9 Million
Q1 2024 Apr 29, 2024	BUY	$170.78 - $208.42 $14.1 Million - $17.2 Million	82,737 Added 31.49%	345,445 $63.5 Million
Q4 2023 Feb 07, 2024	BUY	$114.17 - $185.35 $8 Million - $13 Million	70,033 Added 36.35%	262,708 $47.2 Million
Q3 2023 Nov 02, 2023	SELL	$138.78 - $176.51 $437,018 - $555,829	-3,149 Reduced 1.61%	192,675 $30.6 Million
Q2 2023 Aug 07, 2023	SELL	$138.42 - $180.31 $1.27 Million - $1.65 Million	-9,141 Reduced 4.46%	195,824 $27.7 Million
Q1 2023 May 09, 2023	BUY	$154.26 - $198.1 $133,589 - $171,554	866 Added 0.42%	204,965 $34.5 Million
Q4 2022 Feb 09, 2023	BUY	$162.42 - $220.56 $133,346 - $181,079	821 Added 0.4%	204,099 $34.6 Million
Q3 2022 Nov 09, 2022	SELL	$160.42 - $256.21 $223,144 - $356,388	-1,391 Reduced 0.68%	203,278 $38 Million
Q2 2022 Aug 10, 2022	BUY	$140.68 - $188.02 $4.14 Million - $5.53 Million	29,415 Added 16.78%	204,669 $33.2 Million
Q1 2022 May 09, 2022	SELL	$161.19 - $257.96 $2.56 Million - $4.09 Million	-15,860 Reduced 8.3%	175,254 $33 Million
Q4 2021 Feb 09, 2022	BUY	$247.59 - $304.47 $3.16 Million - $3.89 Million	12,779 Added 7.17%	191,114 $50.6 Million
Q3 2021 Nov 09, 2021	SELL	$194.77 - $324.21 $198,860 - $331,018	-1,021 Reduced 0.57%	178,335 $51.5 Million
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $7.43 Million - $9.9 Million	-44,818 Reduced 19.99%	179,356 $35.8 Million
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $12.9 Million - $16.2 Million	71,722 Added 47.05%	224,174 $43.6 Million
Q4 2020 Feb 08, 2021	BUY	$148.08 - $206.57 $646,073 - $901,264	4,363 Added 2.95%	152,452 $29.2 Million
Q3 2020 Nov 06, 2020	SELL	$122.51 - $158.27 $75,833 - $97,969	-619 Reduced 0.42%	148,089 $21.8 Million
Q2 2020 Aug 05, 2020	BUY	$94.33 - $140.48 $217,713 - $324,227	2,308 Added 1.58%	148,708 $18.4 Million
Q1 2020 May 12, 2020	SELL	$84.96 - $109.14 $5.14 Million - $6.6 Million	-60,491 Reduced 29.24%	146,400 $14.1 Million
Q4 2019 Feb 05, 2020	SELL	$73.84 - $93.08 $893,611 - $1.13 Million	-12,102 Reduced 5.53%	206,891 $19.1 Million
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $10.5 Million - $13.1 Million	-137,332 Reduced 38.54%	218,993 $16.8 Million
Q2 2019 Aug 12, 2019	BUY	$54.2 - $85.95 $639,668 - $1.01 Million	11,802 Added 3.43%	356,325 $30.6 Million
Q1 2019 May 10, 2019	SELL	$49.45 - $62.8 $113,735 - $144,440	-2,300 Reduced 0.66%	344,523 $20.4 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $1.18 Million - $1.69 Million	24,542 Added 7.62%	346,823 $18.3 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $1.11 Million - $1.4 Million	23,703 Added 7.94%	322,281 $17.9 Million
Q2 2018 Aug 13, 2018	SELL	$35.26 - $47.04 $120,730 - $161,064	-3,424 Reduced 1.13%	298,578 $0
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $72,198 - $87,025	2,335 Added 0.78%	302,002 $10.9 Million
Q4 2017 Feb 13, 2018	BUY	$32.53 - $38.92 $84,057 - $100,569	2,584 Added 0.87%	299,667 $10.9 Million
Q3 2017 Nov 02, 2017	BUY	$36.98 - $46.06 $11 Million - $13.7 Million	297,083	297,083 $11.4 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.09 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$923 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$729 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$235 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$205 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account